The robust induction of ANGPTL4, PDK4, and PLIN2 by elafibranor brings up the question of whether or not these lipid metabolism-related genes induce NAFLD-promoting effects. This evidence concerns the gene PLIN2 and metabolic dysfunction-associated steatotic liver disease.